Skip To Main Content
Thierry Dorval on Muck Rack

Thierry Dorval

As seen in: PLOS ONE, LexisNexis, Mondaq
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Thierry

Contact Thierry, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Governance of Publicly Listed Corporations, 3rd Edition

|
By Thierry Dorval
| LexisNexis
This book describes the issues that lie at the crux of corporate governance. It discusses the various legal challenges facing corporate directors today, and examines governance practices that can assist in meeting those challenges. Publication Language: English Published: April 17, 2025 Publisher: LexisNexis Canada Product Format Details Qty Book $190.00 In Stock ISBN: 9780433535911 "Governance standards evolve continuously, as business models and stakeholder expectations do.
Open in Who Shared Issue with article?

A seeding-based neuronal model of tau aggregation for use in drug discovery

|
By Inês S. Amorim, Sylvie Challal, Laetitia Cistarelli, Thierry Dorval
| paperity.org
PLOS ONE, Apr 2023 This is a preview of a remote PDF: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283941&type=printable Ines S. Amorim, Sylvie Challal, Laetitia Cistarelli, Thierry Dorval, Laurene Abjean, Manuelle Touzard, Nicolas Arbez, Arnaud François, Fany Panayi, Ross Jeggo, Erika Cecon, Atsuro Oishi, Julie Dam, Ralf Jockers, Patricia Machado. , PLOS ONE, 2023, Volume 18, Issue 4, DOI: 10.1371/journal.pone.0283941
Open in Who Shared View Duplicates (402) Issue with article?

A seeding-based neuronal model of tau aggregation for use in drug discovery

|
By Inês S. Amorim, Thierry Dorval, Sylvie Challal, Laetitia Cistarelli
| PLOS ONE
Strategies to prevent the formation of tau inclusions Having established the conditions necessary to induce the formation of tau inclusions in hTau primary neurons, we tested how the model responded to molecules aimed at preventing tau aggregation, as these are the focus of many therapeutic approaches for Tauopathies. The oligomer modulator Anle138b has been shown to reduce tau aggregation and delay disease progression in mouse models of Tauopathies [34, 35].
Open in Who Shared Issue with article?
See all 10 articles